A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

The study’s lead author explains how it works.

Pancreatic Cancer Risk Factors: The pancreas is a small organ located behind the stomach, which produces enzymes to digest food and controls blood sugar through hormones like insulin. What are the ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before.

A new era in the treatment of deadly pancreatic cancer was heralded by scientists this week, thanks to research by the ...

Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that ...

A new pancreatic cancer treatment may finally move the needle on what's proved to be an unforgiving disease. Fred Hutch ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...